$3.01
-0.0500 (-1.63%)
At Close: Jun 22, 2026
Biodexa Pharmaceuticals American Depositary Shs Earnings Calls
Dec 31, 2025
-$0.0006 (91.39%)
| Release date | Mar 27, 2026 |
| EPS estimate | -$0.0066 |
| EPS actual | -$0.0006 |
| EPS Surprise | 91.39% |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2025
-$0.0003 (93.20%)
| Release date | Sep 12, 2025 |
| EPS estimate | -$0.0040 |
| EPS actual | -$0.0003 |
| EPS Surprise | 93.20% |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
-$0.0066 (-5.25%)
| Release date | Apr 11, 2025 |
| EPS estimate | -$0.0063 |
| EPS actual | -$0.0066 |
| EPS Surprise | -5.25% |
| Revenue estimate | 16.606K |
| Revenue actual | - |
Jun 30, 2024
-$0.335 (-49.84%)
| Release date | Sep 26, 2024 |
| EPS estimate | -$0.224 |
| EPS actual | -$0.335 |
| EPS Surprise | -49.84% |
| Revenue estimate | 16.606K |
| Revenue actual | - |
Last 4 Quarters for Biodexa Pharmaceuticals American Depositary Shs
Below you can see how BDRX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2024
Missed
| Release date | Sep 26, 2024 |
| Price on release | $36.90 |
| EPS estimate | -$0.224 |
| EPS actual | -$0.335 |
| EPS surprise | -49.84% |
| Date | Price |
|---|---|
| Sep 20, 2024 | $36.50 |
| Sep 23, 2024 | $34.25 |
| Sep 24, 2024 | $36.60 |
| Sep 25, 2024 | $36.45 |
| Sep 26, 2024 | $36.90 |
| Sep 27, 2024 | $35.95 |
| Sep 30, 2024 | $35.30 |
| Oct 01, 2024 | $38.25 |
| Oct 02, 2024 | $34.90 |
| 4 days before | 1.10% |
| 4 days after | -5.42% |
| On release day | -2.57% |
| Change in period | -4.38% |
Dec 31, 2024
Missed
| Release date | Apr 11, 2025 |
| Price on release | $8.85 |
| EPS estimate | -$0.0063 |
| EPS actual | -$0.0066 |
| EPS surprise | -5.25% |
| Date | Price |
|---|---|
| Apr 07, 2025 | $8.25 |
| Apr 08, 2025 | $7.05 |
| Apr 09, 2025 | $7.55 |
| Apr 10, 2025 | $7.85 |
| Apr 11, 2025 | $8.85 |
| Apr 14, 2025 | $8.25 |
| Apr 15, 2025 | $7.30 |
| Apr 16, 2025 | $7.30 |
| Apr 17, 2025 | $7.15 |
| 4 days before | 7.27% |
| 4 days after | -19.21% |
| On release day | -6.78% |
| Change in period | -13.33% |
Jun 30, 2025
Beat
| Release date | Sep 12, 2025 |
| Price on release | $30.10 |
| EPS estimate | -$0.0040 |
| EPS actual | -$0.0003 |
| EPS surprise | 93.20% |
| Date | Price |
|---|---|
| Sep 08, 2025 | $26.60 |
| Sep 09, 2025 | $28.05 |
| Sep 10, 2025 | $28.68 |
| Sep 11, 2025 | $29.65 |
| Sep 12, 2025 | $30.10 |
| Sep 15, 2025 | $30.15 |
| Sep 16, 2025 | $31.30 |
| Sep 17, 2025 | $34.00 |
| Sep 18, 2025 | $32.60 |
| 4 days before | 13.16% |
| 4 days after | 8.31% |
| On release day | 0.166% |
| Change in period | 22.56% |
Dec 31, 2025
Beat
| Release date | Mar 27, 2026 |
| Price on release | $3.27 |
| EPS estimate | -$0.0066 |
| EPS actual | -$0.0006 |
| EPS surprise | 91.39% |
| Date | Price |
|---|---|
| Mar 23, 2026 | $3.42 |
| Mar 24, 2026 | $3.30 |
| Mar 25, 2026 | $3.46 |
| Mar 26, 2026 | $3.30 |
| Mar 27, 2026 | $3.27 |
| Mar 30, 2026 | $3.06 |
| Mar 31, 2026 | $3.09 |
| Apr 01, 2026 | $3.07 |
| Apr 02, 2026 | $4.37 |
| 4 days before | -4.37% |
| 4 days after | 33.51% |
| On release day | -6.50% |
| Change in period | 27.68% |
Biodexa Pharmaceuticals American Depositary Shs Earnings History
Earnings Calendar
FAQ
When is the earnings report for BDRX?
Biodexa Pharmaceuticals Plc American Depositary Shs (BDRX) has scheduled its earnings report for Sep 11, 2026 after the markets close.
What is the BDRX price-to-earnings (P/E) ratio?
BDRX P/E ratio as of Jun 22, 2026 (TTM) is -0.0043.
What is the BDRX EPS forecast?
The forecasted EPS (Earnings Per Share) for Biodexa Pharmaceuticals Plc American Depositary Shs (BDRX) for the first fiscal quarter 2026 is $.
What are Biodexa Pharmaceuticals Plc American Depositary Shs's retained earnings?
On its balance sheet, Biodexa Pharmaceuticals Plc American Depositary Shs reported retained earnings of $0 for the latest quarter ending Dec 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Sign In
Buy BDRX